74 related articles for article (PubMed ID: 3117001)
1. [Results of the surgical treatment of Conn's adenomas].
Pagny JY; Chatellier G; Duclos JM; Plouin PF; Corvol P; Ménard J
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):995-8. PubMed ID: 3117001
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF
J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217
[TBL] [Abstract][Full Text] [Related]
3. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
[TBL] [Abstract][Full Text] [Related]
4. [Primary hyperaldosteronism--12 clinical cases].
Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Biglieri EG; Kater CE; Arteaga EE
J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
[TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism. A follow-up study of 28 cases of surgically treated aldosterone-producing adenomas.
Lins PE; Adamson U
Acta Med Scand; 1987; 221(3):275-82. PubMed ID: 3296673
[TBL] [Abstract][Full Text] [Related]
7. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
11. [Primary hyperaldosteronism: our experience with 34 patients].
Arganini M; Pascucci S; Matteo Cecchini G; Spinelli C; Miccoli P
Ann Ital Chir; 1990; 61(6):603-6. PubMed ID: 2100107
[TBL] [Abstract][Full Text] [Related]
12. Anesthesia and laparoscopic adrenalectomy for primary aldosteronism.
Lertakyamanee N; Somprakit P; Buranakijaroen P; Lertakyamanee J; Nimmanwudipong T; Sriussadaporn S
J Med Assoc Thai; 2001 Jun; 84(6):798-803. PubMed ID: 11556457
[TBL] [Abstract][Full Text] [Related]
13. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
14. Surgical technique and haemodynamic changes in adrenalectomy for secreting neoplasia. Personal experience and review of the literature.
Gullà N; Patriti A; Fabbri B; Lazzarini F; Fabbri C; Tristaino B
Minerva Chir; 2003 Feb; 58(1):87-92. PubMed ID: 12692501
[TBL] [Abstract][Full Text] [Related]
15. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
16. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.
Rossi H; Kim A; Prinz RA
Am Surg; 2002 Mar; 68(3):253-6; discussion 256-7. PubMed ID: 11893103
[TBL] [Abstract][Full Text] [Related]
18. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn's syndrome (primary hyperaldosteronism) between 1999 and 2006.
Herd A; Harman R; Taylor E
N Z Med J; 2010 Oct; 123(1324):50-6. PubMed ID: 20953222
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
